Co-Diagnostics Revenue 2017-2025 | CODX

Co-Diagnostics revenue from 2017 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Co-Diagnostics Annual Revenue
(Millions of US $)
2024 $4
2023 $7
2022 $34
2021 $98
2020 $75
2019 $0
2018 $0
2017 $0
2016 $0
Co-Diagnostics Quarterly Revenue
(Millions of US $)
2025-03-31 $0
2024-12-31 $0
2024-09-30 $1
2024-06-30 $3
2024-03-31 $0
2023-12-31 $4
2023-09-30 $2
2023-06-30 $0
2023-03-31 $1
2022-12-31 $1
2022-09-30 $5
2022-06-30 $5
2022-03-31 $23
2021-12-31 $20
2021-09-30 $30
2021-06-30 $27
2021-03-31 $20
2020-12-31 $27
2020-09-30 $22
2020-06-30 $24
2020-03-31 $2
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31
2016-12-31
2016-09-30
2016-06-30
Sector Industry Market Cap Revenue
Medical Medical Services $0.008B $0.004B
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $132.070B 24.77
Elevance Health (ELV) United States $84.109B 10.85
CVS Health (CVS) United States $76.951B 9.56
Cencora (COR) United States $56.664B 19.71
DiDi Global (DIDIY) China $22.591B 34.29
Natera (NTRA) United States $20.935B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $12.529B 0.00
Solventum (SOLV) United States $12.251B 12.97
CochLear (CHEOY) Australia $11.298B 0.00
Revvity (RVTY) United States $10.529B 18.12
ICON (ICLR) Ireland $10.336B 9.61
Viatris (VTRS) United States $9.730B 3.34
Doximity (DOCS) United States $9.525B 44.37
Avantor (AVTR) United States $8.647B 12.56
HealthEquity (HQY) United States $8.564B 42.13
Medpace Holdings (MEDP) United States $8.476B 22.51
Sonic Healthcare (SKHHY) Australia $8.176B 0.00
Charles River Laboratories (CRL) United States $6.716B 13.16
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.048B 37.47
Bausch + Lomb (BLCO) Canada $3.990B 23.52
Sotera Health (SHC) United States $3.452B 19.61
Surgery Partners (SGRY) United States $2.922B 38.00
Alignment Healthcare (ALHC) United States $2.865B 0.00
Concentras Parent (CON) United States $2.710B 15.66
Organon (OGN) United States $2.259B 2.40
Ardent Health Partners (ARDT) United States $2.091B 8.91
GeneDx Holdings (WGS) United States $2.043B 78.68
Premier (PINC) United States $1.899B 14.41
Progyny (PGNY) United States $1.759B 38.72
PACS (PACS) United States $1.497B 0.00
GoodRx Holdings (GDRX) United States $1.336B 26.71
Teladoc Health (TDOC) United States $1.195B 0.00
Pediatrix Medical (MD) United States $1.165B 8.86
Establishment Labs Holdings (ESTA) $1.059B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.944B 14.74
Agilon Health (AGL) United States $0.919B 0.00
Nutex Health (NUTX) United States $0.890B 13.45
AMN Healthcare Services Inc (AMN) United States $0.795B 7.44
QDM (QDMI) Hong Kong, SAR China $0.743B 0.00
Embecta (EMBC) United States $0.626B 4.22
InnovAge Holding (INNV) United States $0.531B 0.00
LifeMD (LFMD) United States $0.524B 0.00
Enhabit (EHAB) United States $0.518B 42.58
Auna S.A (AUNA) Luxembourg $0.492B 11.08
SBC Medicals (SBC) United States $0.471B 0.00
Sonida Senior Living (SNDA) United States $0.462B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.405B 0.00
Oncology Institute (TOI) United States $0.228B 0.00
Performant Healthcare (PHLT) United States $0.215B 0.00
Beauty Health (SKIN) United States $0.202B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.137B 22.33
OncoCyte (OCX) United States $0.096B 0.00
So-Young (SY) China $0.087B 0.00
Sera Prognostics (SERA) United States $0.066B 0.00
Ascend Wellness Holdings (AAWH) United States $0.061B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.059B 0.00
Biodesix (BDSX) United States $0.050B 0.00
Pheton Holdings (PTHL) China $0.043B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Basel Medical Group (BMGL) Singapore $0.025B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00